Company Registration No. SC307597 (Scotland)
TAYSIDE LASER CLINIC LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
James Hair Group Limited
59 Bonnygate
CUPAR
Fife
UK
KY15 4BY
TAYSIDE LASER CLINIC LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Current assets
Debtors
4
8,704
7,809
Cash at bank and in hand
37,229
29,817
45,933
37,626
Creditors: amounts falling due within one year
5
(2,540)
(3,880)
Net current assets
43,393
33,746
Capital and reserves
Called up share capital
6
1
1
Profit and loss reserves
43,392
33,745
Total equity
43,393
33,746

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 27 August 2025 and are signed on its behalf by:
Dr Ewan Eadie
Director
Company Registration No. SC307597
TAYSIDE LASER CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information

Tayside Laser Clinic Limited is a private company limited by shares incorporated in Scotland. The registered office is Photobiology Unit, Ninewells Hospital, DUNDEE, DD1 9SY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

T urnover comprises the invoiced value of medical laser treatment services provided by the company.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Financial instruments

Basic financial instruments are recognised at amortised cost using the effective interest method except for investments in non-convertible preference and non-puttable preference and ordinary shares, which are measured at fair value, with changes recognised in the profit and loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value, with charges recognised in profit and loss.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

TAYSIDE LASER CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
-
0
-
0
3
Taxation
2024
2023
£
£
Current tax

There is no charge to corporation tax as all profits are gift aided to the company's parent charity within 9 months of the year end.

4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
8,704
7,669
Other debtors
-
0
140
8,704
7,809
5
Creditors: amounts falling due within one year
2024
2023
£
£
Amount due to parent undertaking
-
0
1,800
Other creditors
2,540
2,080
2,540
3,880
6
Called up share capital
2024
2023
£
£
Ordinary share capital
Issued and fully paid
1 Ordinary share of £1 each
1
1
TAYSIDE LASER CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
7
Related party transactions

During the year one director received fees of £NIL (2023 - £4,750).

Tayside Laser Clinic Limited is a wholly owned subsidiary of Laser Research and Therapy Fund. During the year the company gift aided profits of £33,745 (2023 - £38,330) to Laser Research and Therapy Fund. The profit in respect of the current financial year of £43,392 (2023 - £33,745) shall be gift aided to the Laser Research and Therapy fund within 9 months of the year end.

In addition there is a loan due to be repaid to Laser Research and Therapy Fund as of the year end amounting to NIL (2023 - £1,800). Two of the directors, Sally Ibbotson and Harry Mosely are also trustees in Laser Research and Therapy Fund.

8
Parent undertaking

The company is a wholly owned subsidiary of the Laser Research and Therapy Fund, a charity registered in Scotland (charity number SC030850). The charity's principal place of business is The Photobiology Unit, Ninewells Hospital, Dundee, DD1 9SY.

2024-12-31 2024-01-01 false false false 01 September 2025 CCH Software CCH Accounts Production 2025.100 No description of principal activity Professor Harry Moseley Professor S Ibbotson Dr Ewan Eadie Dr A McMullen Dr Ewan Eadie 2025-08-27 SC307597 2024-01-01 2024-12-31 SC307597 2024-12-31 SC307597 2023-12-31 SC307597 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 SC307597 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 SC307597 core:CurrentFinancialInstruments 2024-12-31 SC307597 core:CurrentFinancialInstruments 2023-12-31 SC307597 core:ShareCapital 2024-12-31 SC307597 core:ShareCapital 2023-12-31 SC307597 core:RetainedEarningsAccumulatedLosses 2024-12-31 SC307597 core:RetainedEarningsAccumulatedLosses 2023-12-31 SC307597 core:ShareCapitalOrdinaryShareClass1 2024-12-31 SC307597 core:ShareCapitalOrdinaryShareClass1 2023-12-31 SC307597 bus:Director3 2024-01-01 2024-12-31 SC307597 2023-01-01 2023-12-31 SC307597 core:WithinOneYear 2024-12-31 SC307597 core:WithinOneYear 2023-12-31 SC307597 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 SC307597 bus:FRS102 2024-01-01 2024-12-31 SC307597 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 SC307597 bus:Director1 2024-01-01 2024-12-31 SC307597 bus:Director2 2024-01-01 2024-12-31 SC307597 bus:Director4 2024-01-01 2024-12-31 SC307597 bus:CompanySecretary1 2024-01-01 2024-12-31 SC307597 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 SC307597 bus:FullAccounts 2024-01-01 2024-12-31 xbrli:pure xbrli:shares iso4217:GBP